tiprankstipranks
Trending News
More News >
HealthCo Healthcare & Wellness REIT (AU:HCW)
:HCW
Australian Market

HealthCo Healthcare & Wellness REIT (HCW) AI Stock Analysis

Compare
22 Followers

Top Page

AU

HealthCo Healthcare & Wellness REIT

(Sydney:HCW)

Rating:58Neutral
Price Target:
AU$1.00
▲(35.14%Upside)
HealthCo Healthcare & Wellness REIT's strong revenue growth and operational efficiency are offset by declining profitability and cash flow challenges. The bearish technical trends and negative P/E ratio further weigh on the stock's attractiveness. While the high dividend yield is a positive aspect, the overall outlook remains cautious due to profitability and valuation concerns.

HealthCo Healthcare & Wellness REIT (HCW) vs. iShares MSCI Australia ETF (EWA)

HealthCo Healthcare & Wellness REIT Business Overview & Revenue Model

Company DescriptionHealthCo Healthcare and Wellness REIT operates as a real estate investment trust that focuses on owning healthcare and wellness property assets in Australia. It invests in a portfolio of healthcare property assets, including hospitals, aged care, childcare, government, life sciences and research, primary care, and wellness property assets, as well as other healthcare and wellness property adjacencies. The company was incorporated in 2021 and is headquartered in Sydney, Australia.
How the Company Makes MoneyHealthCo Healthcare & Wellness REIT generates revenue primarily through leasing its properties to healthcare operators and wellness providers. The company enters into long-term lease agreements with tenants, ensuring a stable and predictable income stream. Additionally, HCW may engage in strategic partnerships and joint ventures to expand its portfolio and enhance its service offerings. The company also benefits from property appreciation and may pursue capital recycling strategies by selling underperforming or non-core assets to reinvest in higher-yield opportunities.

HealthCo Healthcare & Wellness REIT Financial Statement Overview

Summary
HealthCo Healthcare & Wellness REIT shows strong revenue growth and operational efficiency with a significant revenue increase of 83.6%, a solid gross profit margin of 77%, and a strong EBIT margin of 93.6%. However, challenges include a declining net profit margin and cash flow pressures, with a significant decrease in free cash flow and return on equity dropping from 2.1% to 0.76%.
Income Statement
75
Positive
HealthCo Healthcare & Wellness REIT has shown a significant revenue growth of 83.6% from 2023 to 2024, indicating strong market performance and expansion. However, the net profit margin decreased from 5.0% in 2023 to 0.9% in 2024, suggesting increased costs or reduced pricing power. The gross profit margin improved to 77%, and the EBIT margin remained strong at 93.6%, reflecting efficient operations despite the lower net income.
Balance Sheet
70
Positive
The company has a low debt-to-equity ratio of 0.53, indicating a conservative leverage position for a REIT. However, the equity ratio has decreased slightly, suggesting a potential increase in liabilities. The return on equity dropped significantly from 2.1% in 2023 to 0.76% in 2024, highlighting reduced profitability on shareholder investments.
Cash Flow
60
Neutral
Free cash flow decreased significantly from 2023 to 2024, potentially impacting the company's ability to fund operations and dividend payments. The operating cash flow to net income ratio is less than optimal, and with a negative free cash flow growth, liquidity might be a concern moving forward. Despite this, the company managed operating cash flows well, maintaining a positive cash position.
BreakdownTTMJun 2024Jun 2023Jun 2022
Income Statement
Total Revenue61.10M64.00M40.20M24.46M
Gross Profit53.00M47.00M24.30M16.31M
EBITDA26.60M49.40M33.80M52.93M
Net Income-3.50M6.90M20.20M49.61M
Balance Sheet
Total Assets1.46B1.44B1.72B693.60M
Cash, Cash Equivalents and Short-Term Investments4.70M19.90M7.60M2.69M
Total Debt491.70M481.10M703.70M22.29M
Total Liabilities519.80M521.50M766.20M39.51M
Stockholders Equity931.00M912.60M951.20M654.09M
Cash Flow
Free Cash Flow15.40M6.40M888.90M-473.92M
Operating Cash Flow15.40M6.40M11.10M19.96M
Investing Cash Flow138.70M41.50M-961.90M-522.47M
Financing Cash Flow-117.70M-35.60M944.10M501.58M

HealthCo Healthcare & Wellness REIT Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.74
Price Trends
50DMA
0.79
Negative
100DMA
0.85
Negative
200DMA
0.95
Negative
Market Momentum
MACD
-0.01
Negative
RSI
44.33
Neutral
STOCH
44.10
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:HCW, the sentiment is Negative. The current price of 0.74 is below the 20-day moving average (MA) of 0.75, below the 50-day MA of 0.79, and below the 200-day MA of 0.95, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 44.33 is Neutral, neither overbought nor oversold. The STOCH value of 44.10 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:HCW.

HealthCo Healthcare & Wellness REIT Peers Comparison

Overall Rating
UnderperformOutperform
Sector (59)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AUSRV
74
Outperform
AU$569.87M10.5025.52%4.77%6.85%237.34%
AUDXC
63
Neutral
AU$406.38M20.504.00%7.10%-0.80%
59
Neutral
C$1.26B-0.04-8.19%4.99%10.83%-22.67%
AUHCW
58
Neutral
AU$404.38M78.69-0.39%11.43%-14.19%-115.93%
AUWOT
56
Neutral
AU$101.90M-1.43%3.17%-6.61%-47.55%
AUCOF
55
Neutral
AU$701.87M-8.21%8.60%-9.52%47.94%
AUAOF
53
Neutral
AU$78.90M-26.33%200.00%-7.19%-94.37%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:HCW
HealthCo Healthcare & Wellness REIT
0.74
-0.37
-33.33%
AU:COF
Centuria Office REIT
1.16
0.04
3.57%
AU:DXC
Dexus Convenience Retail REIT
2.95
0.40
15.69%
AU:AOF
Australian Unity Office Fund
0.48
-0.03
-5.88%
AU:WOT
WOTSO Property
0.63
-0.19
-23.17%
AU:SRV
Servcorp Limited
5.87
1.85
46.02%

HealthCo Healthcare & Wellness REIT Corporate Events

HealthCo Healthcare & Wellness REIT Reports Valuation Decrease and Suspends Quarterly Distribution
Jun 24, 2025

HealthCo Healthcare & Wellness REIT announced a preliminary unaudited portfolio valuation of $1.5 billion, reflecting a 4.3% gross decrease from the previous valuation due to cap rate expansion. The company will not declare a quarterly distribution for the period from April to June 2025 to preserve balance sheet liquidity. Alternative hospital operators are conducting due diligence on all 11 private hospitals owned by HCW and the Unlisted Healthcare Fund. This decision and the valuation adjustment indicate a strategic focus on maintaining financial stability amid market fluctuations.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HealthCo REIT Secures Rent Deferral to Sustain Hospital Operations
May 29, 2025

HealthCo Healthcare & Wellness REIT and the Unlisted Healthcare Fund have agreed to a short-term partial rent deferral with Healthscope and its Receivers to ensure the continuity of services at 11 private hospitals. This agreement includes immediate payment of outstanding rents for March and April 2025, and 85% of rent for May 2025, with the remaining 15% deferred until September 2025. The landlords are also in discussions about the Healthscope sale process and have received interest from other hospital operators to re-tenant the facilities, indicating a strategic move to maintain operations and explore new partnerships.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HealthCo REIT Maintains Stability Amid Healthscope Receivership
May 27, 2025

HealthCo Healthcare & Wellness REIT (ASX:HCW) and the Unlisted Healthcare Fund (UHF) have announced that two entities within the Healthscope group have entered into receivership and administration. However, the entities that HCW and UHF contract with remain operational and unaffected by the receivership. The existing legal rights of HCW and UHF, including cross default and termination rights, remain intact, although termination rights are not currently enforceable. This situation underscores the resilience of HCW’s operations and its strategic positioning in the healthcare property market, ensuring stakeholders that their investments remain secure despite the challenges faced by Healthscope.

The most recent analyst rating on (AU:HCW) stock is a Sell with a A$1.04 price target. To see the full list of analyst forecasts on HealthCo Healthcare & Wellness REIT stock, see the AU:HCW Stock Forecast page.

HMC Capital Showcases Strategic Strengths at Macquarie Conference
May 5, 2025

HMC Capital presented at the 2025 Macquarie Australia Conference, highlighting its strategic focus and operational strengths. The presentation underscores HMC Capital’s ability to manage substantial funds and execute complex deals, reinforcing its position in the alternative asset management industry and its commitment to delivering strong returns for its investors.

HealthCo REIT Announces Cessation of Securities via Buy-Back
Apr 22, 2025

HealthCo Healthcare & Wellness REIT announced the cessation of 10,827,051 ordinary units, which were canceled as part of an on-market buy-back program completed on December 31, 2024. This strategic move is likely aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting a proactive approach in managing its financial resources.

HealthCo Completes Significant Buy-Back of Ordinary Units
Apr 22, 2025

HealthCo Healthcare & Wellness REIT has completed a buy-back of 18,188,371 ordinary units, with a total consideration of AUD 20,151,127.44. This buy-back, finalized on April 22, 2025, reflects the company’s strategic decision to manage its capital structure, potentially enhancing shareholder value and signaling confidence in its financial position.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 03, 2025